Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;174(12):1768-1770.
doi: 10.7326/M21-2483. Epub 2021 Oct 12.

Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease

Gil Y Melmed  1 , Gregory J Botwin  1 , Kimia Sobhani  2 , Dalin Li  1 , John Prostko  3 , Jane Figueiredo  4 , Susan Cheng  5 , Jonathan Braun  6 , Dermot P B McGovern  6
Affiliations

Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease

Gil Y Melmed et al. Ann Intern Med. 2021 Dec.

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M21-2483.

Figures

Figure.
Figure.. Week 8 anti-spike IgG (log10) levels, by medication class.
The dotted line represents the threshold for a positive antibody result (50 AU/mL [Abbott Labs]). IL = interleukin; JAK = Janus kinase; TNF = tumor necrosis factor-α.
See this image and copyright information in PMC

References

    1. Wallace BI , Kenney B , Malani PN , et al. Prevalence of immunosuppressive drug use among commercially insured US adults, 2018-2019. JAMA Netw Open. 2021;4:e214920. [PMID: ] doi:10.1001/jamanetworkopen.2021.4920 - DOI - PMC - PubMed
    1. Boyarsky BJ , Werbel WA , Avery RK , et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325:2204-2206. [PMID: ] doi:10.1001/jama.2021.7489 - DOI - PMC - PubMed
    1. Kennedy NA , Lin S , Goodhand JR , et al; Contributors to the CLARITY IBD study. Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD. Gut. 2021;70:1884-1893. [PMID: ] doi:10.1136/gutjnl-2021-324789 - DOI - PubMed
    1. Wong SY , Dixon R , Martinez Pazos V , et al; ICARUS-IBD Working Group. Serologic response to messenger RNA coronavirus disease 2019 vaccines in inflammatory bowel disease patients receiving biologic therapies. Gastroenterology. 2021;161:715-718.e4. [PMID: ] doi:10.1053/j.gastro.2021.04.025 - DOI - PMC - PubMed
    1. Kappelman MD , Weaver KN , Boccieri M , et al; PREVENT-COVID Study Group. Humoral immune response to messenger RNA COVID-19 vaccines among patients with inflammatory bowel disease. Gastroenterology. 2021;161:1340-1343.e2. [PMID: ] doi:10.1053/j.gastro.2021.06.016 - DOI - PMC - PubMed